Other authors indicated that mice that were fed HFD and were treated with G49, a GLP-1/GCG RA, showed the amelioration of MASH, as evaluated by reduced inflammation, steatosis, oxidative stress, and hepatocyte apoptosis, as well as increased mitochondrial biogenesis [84]. Here, GLP1R is linked to steatosis.